0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Isometric Exercise Training and Arterial Hypertension: An Updated Review

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Hypertension is recognised as a leading attributable risk factor for cardiovascular disease and premature mortality. Global initiatives towards the prevention and treatment of arterial hypertension are centred around non-pharmacological lifestyle modification. Exercise recommendations differ between professional and scientific organisations, but are generally unanimous on the primary role of traditional aerobic and dynamic resistance exercise. In recent years, isometric exercise training (IET) has emerged as an effective novel exercise intervention with consistent evidence of reductions in blood pressure (BP) superior to that reported from traditional guideline-recommended exercise modes. Despite a wealth of emerging new data and endorsement by select governing bodies, IET remains underutilised and is not widely prescribed in clinical practice. This expert-informed review critically examines the role of IET as a potential adjuvant tool in the future clinical management of BP. We explore the efficacy, prescription protocols, evidence quality and certainty, acute cardiovascular stimulus, and physiological mechanisms underpinning its anti-hypertensive effects. We end the review with take-home suggestions regarding the direction of future IET research.

          Related collections

          Most cited references188

          • Record: found
          • Abstract: found
          • Article: not found

          A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

          The Lancet, 380(9859), 2224-2260
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

            Summary Background Global development goals increasingly rely on country-specific estimates for benchmarking a nation's progress. To meet this need, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 estimated global, regional, national, and, for selected locations, subnational cause-specific mortality beginning in the year 1980. Here we report an update to that study, making use of newly available data and improved methods. GBD 2017 provides a comprehensive assessment of cause-specific mortality for 282 causes in 195 countries and territories from 1980 to 2017. Methods The causes of death database is composed of vital registration (VR), verbal autopsy (VA), registry, survey, police, and surveillance data. GBD 2017 added ten VA studies, 127 country-years of VR data, 502 cancer-registry country-years, and an additional surveillance country-year. Expansions of the GBD cause of death hierarchy resulted in 18 additional causes estimated for GBD 2017. Newly available data led to subnational estimates for five additional countries—Ethiopia, Iran, New Zealand, Norway, and Russia. Deaths assigned International Classification of Diseases (ICD) codes for non-specific, implausible, or intermediate causes of death were reassigned to underlying causes by redistribution algorithms that were incorporated into uncertainty estimation. We used statistical modelling tools developed for GBD, including the Cause of Death Ensemble model (CODEm), to generate cause fractions and cause-specific death rates for each location, year, age, and sex. Instead of using UN estimates as in previous versions, GBD 2017 independently estimated population size and fertility rate for all locations. Years of life lost (YLLs) were then calculated as the sum of each death multiplied by the standard life expectancy at each age. All rates reported here are age-standardised. Findings At the broadest grouping of causes of death (Level 1), non-communicable diseases (NCDs) comprised the greatest fraction of deaths, contributing to 73·4% (95% uncertainty interval [UI] 72·5–74·1) of total deaths in 2017, while communicable, maternal, neonatal, and nutritional (CMNN) causes accounted for 18·6% (17·9–19·6), and injuries 8·0% (7·7–8·2). Total numbers of deaths from NCD causes increased from 2007 to 2017 by 22·7% (21·5–23·9), representing an additional 7·61 million (7·20–8·01) deaths estimated in 2017 versus 2007. The death rate from NCDs decreased globally by 7·9% (7·0–8·8). The number of deaths for CMNN causes decreased by 22·2% (20·0–24·0) and the death rate by 31·8% (30·1–33·3). Total deaths from injuries increased by 2·3% (0·5–4·0) between 2007 and 2017, and the death rate from injuries decreased by 13·7% (12·2–15·1) to 57·9 deaths (55·9–59·2) per 100 000 in 2017. Deaths from substance use disorders also increased, rising from 284 000 deaths (268 000–289 000) globally in 2007 to 352 000 (334 000–363 000) in 2017. Between 2007 and 2017, total deaths from conflict and terrorism increased by 118·0% (88·8–148·6). A greater reduction in total deaths and death rates was observed for some CMNN causes among children younger than 5 years than for older adults, such as a 36·4% (32·2–40·6) reduction in deaths from lower respiratory infections for children younger than 5 years compared with a 33·6% (31·2–36·1) increase in adults older than 70 years. Globally, the number of deaths was greater for men than for women at most ages in 2017, except at ages older than 85 years. Trends in global YLLs reflect an epidemiological transition, with decreases in total YLLs from enteric infections, respiratory infections and tuberculosis, and maternal and neonatal disorders between 1990 and 2017; these were generally greater in magnitude at the lowest levels of the Socio-demographic Index (SDI). At the same time, there were large increases in YLLs from neoplasms and cardiovascular diseases. YLL rates decreased across the five leading Level 2 causes in all SDI quintiles. The leading causes of YLLs in 1990—neonatal disorders, lower respiratory infections, and diarrhoeal diseases—were ranked second, fourth, and fifth, in 2017. Meanwhile, estimated YLLs increased for ischaemic heart disease (ranked first in 2017) and stroke (ranked third), even though YLL rates decreased. Population growth contributed to increased total deaths across the 20 leading Level 2 causes of mortality between 2007 and 2017. Decreases in the cause-specific mortality rate reduced the effect of population growth for all but three causes: substance use disorders, neurological disorders, and skin and subcutaneous diseases. Interpretation Improvements in global health have been unevenly distributed among populations. Deaths due to injuries, substance use disorders, armed conflict and terrorism, neoplasms, and cardiovascular disease are expanding threats to global health. For causes of death such as lower respiratory and enteric infections, more rapid progress occurred for children than for the oldest adults, and there is continuing disparity in mortality rates by sex across age groups. Reductions in the death rate of some common diseases are themselves slowing or have ceased, primarily for NCDs, and the death rate for selected causes has increased in the past decade. Funding Bill & Melinda Gates Foundation.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A Randomized Trial of Intensive versus Standard Blood-Pressure Control

              New England Journal of Medicine, 373(22), 2103-2116
                Bookmark

                Author and article information

                Contributors
                jamie.odriscoll@canterbury.ac.uk
                Journal
                Sports Med
                Sports Med
                Sports Medicine (Auckland, N.z.)
                Springer International Publishing (Cham )
                0112-1642
                1179-2035
                19 May 2024
                19 May 2024
                2024
                : 54
                : 6
                : 1459-1497
                Affiliations
                [1 ]School of Psychology and Life Sciences, Canterbury Christ Church University, ( https://ror.org/0489ggv38) Kent, CT1 1QU UK
                [2 ]GRID grid.412295.9, ISNI 0000 0004 0414 8221, Graduate Program in Rehabilitation Sciences, , University Nove de Julho, ; São Paulo, Brazil
                [3 ]Department of Physical Education, Universidade Federal Rural de Pernambuco, ( https://ror.org/02ksmb993) Recife, Brazil
                [4 ]National Centre for Sport and Exercise Medicine, School of Sport, Exercise and Health Sciences, Loughborough University, ( https://ror.org/04vg4w365) Loughborough, UK
                [5 ]GRID grid.269014.8, ISNI 0000 0001 0435 9078, NIHR Leicester Biomedical Research Centre, , University Hospitals of Leicester NHS Trust and the University of Leicester, ; Leicester, UK
                [6 ]Faculty of Sport Sciences, Waseda University, ( https://ror.org/00ntfnx83) Tokyo, Japan
                [7 ]GRID grid.10784.3a, ISNI 0000 0004 1937 0482, Department of Sports Science and Physical Education, , The Chinese University of Hong Kong, ; Hong Kong, China
                [8 ]School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, ( https://ror.org/03angcq70) Birmingham, UK
                [9 ]Human Cardiovascular Physiology Laboratory, Department of Human Health and Nutritional Sciences, College of Biological Sciences, University of Guelph, ( https://ror.org/01r7awg59) Guelph, ON Canada
                [10 ]Department of Health and Human Development, University of Pittsburgh, ( https://ror.org/01an3r305) Pittsburgh, PA USA
                [11 ]Department of Rehabilitation Sciences, KU Leuven, ( https://ror.org/05f950310) Leuven, Belgium
                [12 ]School of Science and Technology, University of New England, ( https://ror.org/04r659a56) Armidale, NSW Australia
                [13 ]GRID grid.1023.0, ISNI 0000 0001 2193 0854, School of Health, Medical and Applied Sciences, , CQ University, ; North Rockhampton, QLD Australia
                [14 ]Department of Kinesiology, University of Windsor, ( https://ror.org/01gw3d370) Windsor, ON Canada
                [15 ]Sport Science, University of Greenwich, ( https://ror.org/00bmj0a71) London, UK
                [16 ]Department of Kinesiology, University of Connecticut, ( https://ror.org/02der9h97) Storrs, CT 06269 USA
                [17 ]GRID grid.266859.6, ISNI 0000 0000 8598 2218, Department of Applied Physiology, Health and Clinical Sciences, , UNC Charlotte, ; Charlotte, NC 28223 USA
                [18 ]Department of Applied Sport and Exercise Science, University of East London, ( https://ror.org/057jrqr44) London, UK
                [19 ]Centre for Health Services Studies, University of Kent, ( https://ror.org/00xkeyj56) Canterbury, UK
                [20 ]Oxford Clinical Cardiovascular Research Facility, Department of Cardiovascular Medicine, University of Oxford, ( https://ror.org/052gg0110) Oxford, UK
                [21 ]Department of Cardiology, St George’s University Hospitals NHS Foundation Trust, ( https://ror.org/039zedc16) Blackshaw Road, Tooting, London, SW17 0QT UK
                Author information
                http://orcid.org/0000-0002-5923-4798
                Article
                2036
                10.1007/s40279-024-02036-x
                11239608
                38762832
                e06a9d08-4999-428b-8f14-cfa9203c2f8a
                © The Author(s) 2024

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 8 April 2024
                Categories
                Review Article
                Custom metadata
                © Springer Nature Switzerland AG 2024

                Comments

                Comment on this article